Gary Lifchus is an innovative and results-driven executive with extensive cross-functional experience in the biotech and pharmaceutical industries. They held several key roles, including CFO of the Biologics R&D Division at Merck and Director of Field Strategy at Genentech, where they successfully guided teams in optimizing sales efforts and developing strategic insights. Currently, Gary serves as an Executive Director at Gilead Sciences, specializing in Liver, Rare Disease, and COVID, while also providing strategy and analytics consulting through SKL Consulting. Gary earned their degree from the University of California, Berkeley - Walter A. Haas School of Business.
This person is not in any teams
This person is not in any offices